Why the study?
The prevalence and clinical consequences of additional rare genetic variants in cardiomyopathy- and/or channelopathy-related genes in PLN p.(Arg14del) patients were unknown.
Does the presence of additional (likely) pathogenic genetic variants worsen the clinical course (earlier onset of MVA or HF events) in PLN p.(Arg14del) cardiomyopathy patients?
Does the presence of additional (likely) pathogenic genetic variants worsen the clinical course (earlier onset of MVA or HF events) in PLN p.(Arg14del) cardiomyopathy patients?
Additional pathogenic variants in PLN p.(Arg14del) patients are present in 6% of cases and may be associated with a trend toward earlier onset of severe arrhythmias or heart failure.
Answers are grounded in this paper and cite their sources.
Additional variants may modify PLN cardiomyopathy course; leaves open whether expanded testing refines risk stratification.
AIMS: To evaluate the prevalence and clinical consequences of additional rare genetic variants in cardiomyopathy- and/or channelopathy-related genes in PLN p.(Arg14del) patients. METHODS: In PLN p.(Arg14del) index patients (n = 160), additional rare genetic variants in cardiomyopathy- or channelopathy-related genes were collected. These variants were (re)classified as either variants of uncertain significance (VUS) or (likely) pathogenic ((L)P). VUS were further subcategorized in low, mid or high suspicion VUS. Cascade genetic testing results were studied in families with an additional (L)P variant. The occurrence and onset of malignant ventricular arrhythmias (MVA) or severe heart failure (HF)-related events in PLN index patients with and without additional (L)P variants were compared. In addition, extended genetic testing was performed in PLN relatives (n = 8) with major cardiac events <45 year. RESULTS: In 6 % (6/106) of PLN index patients in whom targeted gene panel analysis was performed, an additional (L)P variant was identified. These patients showed a non-significant trend towards earlier onset of MVA or a severe HF-related event versus those without an additional variant. Incorporating VUS subclassification did not alter either of these trends. Two out of 8 PLN relatives with a major cardiac event <45 year had an additional P variant. CONCLUSION: Additional (L)P variants in established cardiomyopathy- or channelopathy-related genes were found in 6 % of PLN p.(Arg14del) index patients, which is higher than in control populations. These patients showed a trend towards earlier onset of MVA or HF-related symptoms.
No takes yet. Share an insight, caveat, or question.
Drie et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: